Most Popular
-
1
Yoon's approval rating plunges to all-time low
-
2
Bae Doo-na shares portraying Korean identity in Hollywood's 'Rebel Moon'
-
3
S. Korea votes in favor of Palestinian bid for UN membership
-
4
[From the Scene] Monks, Buddhists hail return of remains of Buddhas
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
-
5
Medical schools granted enrollment quota flexibility for next year
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
-
6
Yoon offers first one-on-one meeting with opposition leader next week
-
7
France rejects opening Paris flight routes to T'way Air, deals blow to Korean Air merger
-
8
Chinese man behind drug scam targeting teens nabbed in Cambodia
-
9
Iran fires air defense batteries in provinces as sound of explosions heard near Isfahan
-
10
[Graphic News] French bulldog most popular breed in US, Maltese most popular in Korea
![[Graphic News] French bulldog most popular breed in US, Maltese most popular in Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050864_0.gif&u=)
![[Graphic News] French bulldog most popular breed in US, Maltese most popular in Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050864_0.gif&u=)
German pharmaceutical company Merck said Monday its sales and earnings rose significantly in 2016, as major strategic advances were made in all three business sectors.
“2016 was a successful year for Merck. In health care, two of our compounds are in registration. In our life science business sector, we made rapid progress with the integration of Sigma-Aldrich. We have moved ahead faster and even better than expected with the realization of synergies,” said Merck CEO through the company’s statement.
The company said its net sales increased by 17 percent to reach $16 billion in 2016 and all regions contributed to organic sales growth of 3.2 percent.
The purchase of Sigma-Aldrich was also responsible for an acquisition-related sales increase of 16.4 percent, Merck said.
By Shin Ji-hye(shinjh@heraldcorp.com)
신지혜기자@heraldcorp.com
“2016 was a successful year for Merck. In health care, two of our compounds are in registration. In our life science business sector, we made rapid progress with the integration of Sigma-Aldrich. We have moved ahead faster and even better than expected with the realization of synergies,” said Merck CEO through the company’s statement.
The company said its net sales increased by 17 percent to reach $16 billion in 2016 and all regions contributed to organic sales growth of 3.2 percent.
The purchase of Sigma-Aldrich was also responsible for an acquisition-related sales increase of 16.4 percent, Merck said.
By Shin Ji-hye(shinjh@heraldcorp.com)
신지혜기자@heraldcorp.com
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
![[Today’s K-pop] Illit drops debut single remix](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/19/20240419050612_0.jpg&u=)